Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

In Brief: Abbott Laboratories/Home Access

This article was originally published in The Gray Sheet

Executive Summary

Abbott Laboratories/Home Access: Firms ink exclusive agreement to collaborate on development and marketing of home diagnostic tests employing Home Access' telemedicine test reporting and patient counseling service. Under the terms of the deal, Abbott will market tests to be developed by Home Access, which is responsible for gaining FDA approval and for providing related test result counseling services. Financial terms were not disclosed. Hoffman Estates, Illinois-based Home Access says that it is conducting research in the areas of genetics, cancer, drug testing, reproductive health and nutrition. The firm is currently the only company marketing FDA-approved at-home diagnostic tests with counseling services (telemedicine) -- the Home Access and Home Access Express HIV test systems. The firm notes that the home diagnostic tests under development likely will function along the same lines as the Home Access HIV test systems, which allow people to obtain the test sample at home and anonymously obtain the results by phone...

Latest Headlines
See All
UsernamePublicRestriction

Register

MT008709

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel